Monday, September 30, 2013

• Credit Suisse Lowers Price Target On Arena, What's Next?at Seeking Alpha (Mon, Sep 30)
• Comcast Readies Bid for Houston Astros Carrier and 2 More Heavily Traded Stocks to Followat Wall St. Cheat Sheet (Mon, Sep 30)
• Will Arena Be Able To Write A Growth Story?at Seeking Alpha (Mon, Sep 30)
• Arena Pharma falls after analyst cuts outlookAP (Mon, Sep 30)
• Valuing the Next Obesity Drugmakerat Motley Fool (Mon, Sep 30)
• Arena Pharmaceuticals price target lowered to $4 from $5 at Credit Suissetheflyonthewall.com (Mon, Sep 30)

Saturday, September 28, 2013

• For Arena, Belviq Refills Are Becoming Keyat Seeking Alpha (Sat, Sep 28)

Friday, September 27, 2013

• First Week of December 21st Options Trading For Arena Pharmaceuticals (ARNA)at Forbes (Fri, Sep 27)
• Arena Sales - Pacing Along Modestlyat Seeking Alpha (Fri, Sep 27)

Thursday, September 26, 2013

• What's Weighing on Obesity Drug Makers Vivus and Arena?at Minyanville (Thu, Sep 26)
• Biotech Investors: Be Careful Who You Listen Toat Motley Fool (Thu, Sep 26)

Wednesday, September 25, 2013

• VIVUS' Hopes Tied to QsymiaZacks (Wed, Sep 25)

Tuesday, September 24, 2013

• When the EMA Says No, Try, Try, and Try Againat Motley Fool (Tue, Sep 24)
• Novo Nordisk Advertising Weight Loss - A Future Peak At Arena Or Vivus?at Seeking Alpha (Tue, Sep 24)

Monday, September 23, 2013

• Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry ConferencePR Newswire (Mon, Sep 23)

Sunday, September 22, 2013

• 4 Health-Care Industry Predictions for the Next 20 Yearsat Motley Fool (Sun, Sep 22)

Saturday, September 21, 2013

• Does This Company Have a Clear Path to European Anti-Obesity Approval?at Motley Fool (Sat, Sep 21)

Friday, September 20, 2013

• The Biggest Loser: A Compelling Short Opportunity In Vivusat Seeking Alpha (Fri, Sep 20)
• Vivus Will Try Again In Europe With Anti-Obesity Drugat Seeking Alpha (Fri, Sep 20)
• Arena's Belviq Sales Week 14: Back On Track?at Seeking Alpha (Fri, Sep 20)

Add ARNA News to My Yahoo!